This document discusses pharmacovigilance, which refers to the monitoring of medicines to detect and prevent adverse effects. The objectives of pharmacovigilance include improving patient safety, public health, and rational drug use. It is important due to limitations of clinical trials and the need to ensure drugs are used safely. Governing bodies that oversee pharmacovigilance include regulatory authorities and the WHO. Methods of monitoring include individual case reports, cohort studies, and periodic safety reports submitted by drug companies. Major adverse drug reactions that prompted increased pharmacovigilance include those from sulphanilamide and thalidomide. The scope of pharmacovigilance aims to improve understanding and safe use of medicines.
History and Progress of Pharmacovigilance, Significance of Safety Monitoring, Pharmacovigilance in India And International Aspects, WHO International Drug Monitoring Programme, WHO and Regulatory Terminologies of ADR, Evaluation of Medication Safety, Establishing Pharmacovigilance Centres in Hospitals, Industry and National Programmes Related to Pharmacovigilance, Roles and Responsibilities in Pharmacovigilance, International Non-Proprietary Names for Drugs, International Classification of Diseases, Passive and Active Surveillance, Comparative Observational Studies, Targeted Clinical Investigations and Vaccine Safety Surveillance, Aris G Pharmacovigilance, VigiFlow, Statistical Methods for Evaluating Medication Safety Data
History and Progress of Pharmacovigilance, Significance of Safety Monitoring, Pharmacovigilance in India And International Aspects, WHO International Drug Monitoring Programme, WHO and Regulatory Terminologies of ADR, Evaluation of Medication Safety, Establishing Pharmacovigilance Centres in Hospitals, Industry and National Programmes Related to Pharmacovigilance, Roles and Responsibilities in Pharmacovigilance, International Non-Proprietary Names for Drugs, International Classification of Diseases, Passive and Active Surveillance, Comparative Observational Studies, Targeted Clinical Investigations and Vaccine Safety Surveillance, Aris G Pharmacovigilance, VigiFlow, Statistical Methods for Evaluating Medication Safety Data
PHARMACOVIGILANCE
The World Health Organization (WHO) defines Pharmacovigilance as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.”
ADVERSE DRUG REACTION
According to WHO “ADR is a response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of physiological function.”
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
Slides includes ADR monitoring process, Safety reporting, what is pharmacovigilance, types of ADR, basic terms in ADR monitoring, what is PvPI in India, role. stakeholders, ADR reporting form, Apps, Role of community Pharmacist in ADR monitoring, Importance of ADR monitoring, etc.
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSKatalyst HLS
Introduction to Drug Safety & Pharmacovigilance in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
complete description of causality assessment with the definition of basic terminologies.& relation with an adverse event and adverse drug reaction, causality terms & assessment criteria.
Pharmacovigilance Process Work Flow - Katalyst HLSKatalyst HLS
Introduction to Drug Safety & Pharmacovigilance Process Work Flow for Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
Karen Hoare - Three Essential Steps to Avoiding A Health, Safety, & Environme...John Blue
Three Essential Steps to Avoiding A Health, Safety, & Environmental Disaster - Karen Hoare, National Pork Board, from the 2016 World Pork Expo, June 8 - 10, 2016, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-world-pork-expo
PHARMACOVIGILANCE
The World Health Organization (WHO) defines Pharmacovigilance as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.”
ADVERSE DRUG REACTION
According to WHO “ADR is a response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of physiological function.”
If you are marketing your product in India you should comply these area of regulation.We give Services in getting manufacturing licences
ACCREDITED CONSULTANTS PVT.LTD
info@acplgroupindia.co.in
+919310040434
Slides includes ADR monitoring process, Safety reporting, what is pharmacovigilance, types of ADR, basic terms in ADR monitoring, what is PvPI in India, role. stakeholders, ADR reporting form, Apps, Role of community Pharmacist in ADR monitoring, Importance of ADR monitoring, etc.
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSKatalyst HLS
Introduction to Drug Safety & Pharmacovigilance in Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
complete description of causality assessment with the definition of basic terminologies.& relation with an adverse event and adverse drug reaction, causality terms & assessment criteria.
Pharmacovigilance Process Work Flow - Katalyst HLSKatalyst HLS
Introduction to Drug Safety & Pharmacovigilance Process Work Flow for Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Cosmeceuticals and Foods.
Contact:
"Katalyst Healthcares & Life Sciences"
South Plainfield, NJ, USA
info@KatalystHLS.com
Karen Hoare - Three Essential Steps to Avoiding A Health, Safety, & Environme...John Blue
Three Essential Steps to Avoiding A Health, Safety, & Environmental Disaster - Karen Hoare, National Pork Board, from the 2016 World Pork Expo, June 8 - 10, 2016, Des Moines, IA, USA.
More presentations at http://www.swinecast.com/2016-world-pork-expo
The aim of Safety reports is describe the safety during the lifecycle of the medicinal product. These reports are necessary during development as well as during the authorization process or renewal. In addition, several of these reports may be required by Health Authorities in case of safety concerns.
This presentation contains a full overview about periodic safety update reports and all the information related with it.
General principles of Periodic Safety Update Reports(PSUR)Psur by Julia Appel...László Árvai
The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Bluefish Pharmaceuticals.
Clinical pharmacokinetic studies are performed to examine the absorption, distribution, metabolism, and excretion of a drug under investigation in healthy volunteers and/or patients
This ppt is about pharmacovigilance in India & spontaneous reporting of adverse drug effect and there regulation by WHO or uppsala. It also include drug interaction in herbal medicine.
PHARMACOVIGILANCE - A Worldwide masterkey for Drug MonitoringVenugopal N
Pharmacovigilance is the pharmacological science that aims at the detection, assessment, monitoring, understanding and prevention of adverse effects, particularly long term and short term side effects of medicines to ensure drug safety.
Introduction to Pharmacovigilance
History and development of Pharmacovigilance
Importance of safety monitoring of Medicine
WHO international drug monitoring programme
Pharmacovigilance Program of India(PvPI)
Pharmacovigilance is defined as, The pharmacological science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions to medicines or Pharmacovigilance is the name given to the mechanisms and controls that together map and ensure the safety of a medicine throughout its life span – from test tube to patient.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem.
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.
a presentation in CME activities by Saad Specialist Hospital, KSA
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
2. CONTENTS
• INTRODUCTION
• OBJECTIVES
• RESPONSIBILITY
• NEED OF PHARMACOVIGILANCE
• GOVERNING BODIES
• METHOD OF PHARMACOVIGILANCE
• ADVERSE DRUG REACTIONS
• SCOPE OF PHARMACOVIGILANCE
• REFERENCE
3. INTRODUCTION
Pharmacovigilance (PV) also called as drug safety
Pharmakon --- in Greek -- drug
Vigilance --- in Latin -- to keep watch
The science and activities relating to the
detection, assessment, understanding and
prevention of adverse affects or any other
possible drug-related problems
:
4. OBJECTIVES
• To improve patient care and safety
• To improve public health and safety
• To contribute to the assessment of benefit,
harm, effectiveness and risk of medicines
• To promote education and clinical training
• To promote rational and safe use of
medicines
• Tracking any drastic effects of drugs
5. RESPONSIBILITIES
• Time to time collection of data, recording and
notification
• Appropriate assessments (data completeness,
seriousness)
• Expedited and periodic reporting
• Creates appropriate structures for
communication
7. 1. Humanitarian concern
• Animal toxicology is often not a good predictor for human effects
• Evidence of safety from clinical trials is insufficient due to some
limitations
2. Safe use of medicines
Dying from a disease is sometimes unavoidable; dying from a
medicine is unacceptable - Lepakhin V. Geneva 2005
• It has been suggested that ADRs may cause 5700 deaths
per year in UK
• ADRs were 4th-6th commonest cause of death in the US in 1994
8. Continue..
3. To reduce healthcare expenses - ADRs are
huge burden
4. Ensuring the public confidence
5. Ethical concern
• To know something which is harmful to
another person who does not know, and not
telling is unethical
9. GOVERNING BODIES
• The pharmaceutical industry
• Regulatory authorities
• WHO collaborating centre for international drug
monitoring
• CIOMS(Council for International
Organization of Medical Sciences )
10. METHOD OF
PHARMACOVIGILANCE
1. Individual case safety reports
2. Clinical review of case reports
3. Cohort event monitoring
4. Longitudinal electronic patient records
5. Periodic Safety Update Reports (PSUR)
6. Expedited report
7. Record linkage
11. Individual case safety reports
• Like Yellow card system which is used in UK in
pharmacovigilance
• By this scheme they collect information on
suspected ADRs to medicines & the scheme
allow the safety to the medicines & vaccines
that are on the market to be monitored
12. YELLOW CARD SCHEME
• This scheme was founded in 1964 after the
thalidomide disaster was developed & also
run by medicines and healthcare product
regulatory agency (MHRA) or the commission
of human medicines
• It also include all herbal preparation or these
ADRs can be reported by pharmacist, doctor,
nurse or even patients also
13.
14. CLINICAL REVIEW OF CASE
REPORT
• The quality of report is variable through
nation to nation or international organization
collect hundreds or thousands of report each
year and this is not possible to review all
report by the available experts
• Even if each report could be reviewed,
important reporting pattern would
be missed
15. COHORT EVENT MONITORING
Cohort Event Monitoring (CEM) systems for
intensified follow up of selected medicinal
products
The main limitations are its restriction to small
subset of medicinal products, the relatively
small fraction of the population covered
16. LONGITUDINAL ELECTRONIC
PATIENT RECORDS
• It is extremely valuable but still in used
• They cover large population, provide detailed
information on both exposed and unexposed
patients
• Information is extracted directly from the
computer systems in which physicians store
patient’s data
17. PERIODIC SAFETY UPDATE
REPORTS (PSUR)
• Pre marketing clinical trials may not be
sufficient to reflect the product safety profile
• Therefore medically advanced countries
impose the “post marketing drug safety
monitoring period ” on new drugs
• License holders shall proactively collect post
marketing safety data, prepare PSUR and submit
them to the health authority
18. CONTINUE..
•According to the “regulation of medical products under
safety monitoring”, if pharmaceutical companies fail to
submit PSUR as required, then the health authority may
consider the safety of the concerned product
• The last PSUR should be submitted before the
expiration of the drug safety monitoring period
•The “summary bridging report” provides summarized
information of the PSURs
19. EXPEDITED REPORT
• If there has been spontaneous reporting of a
suspected ADR to a pharmaceutical company,
there are legal obligations on the company to
report serious reactions within a specified time
frame to the regulatory authority
• Based on the results of drug safety assessment,
license holders shall report to the health
authorities in an expedited manner
20. ADVERSE DRUG REACTIONS
• In year 1932 it was
introduced for treatment
of streptococcal
infections in a elixir or
syrup dosages form
• But, in year 1937
sulphanilamide is
withdrawal from market
because it was
responsible for death of
105 individuals
21. THALIDOMIDE DISASTERS
• In year 1957
thalidomide was
introduced in market
for treatment of
morning sickness &
nausea
• And in year 1961 it was
withdrawal from the
market due to massive
pressure from press and
public
22. Continue..
• ADVERSE Drug Events- ADE, harm caused by
the drug (ADR & overdoses) and harm from the
use of the drug (including dose reductions &
discontinuations of drug therapy)
• ADVERSE Drug Reactions- are response to the
drug which is noxious & unintended which occurs
due to doses normally used in man for the
prophylaxis, diagnosis or therapy of disease.
There is causal link between a drug & an adverse
drug reaction
23. Continue..
•Side effects
undesirable and unavoidable effects of drugs due to
their pharmacological property at recommended doses
Ex-dry mouth from atropine therapy
•Toxic effect
It is a pharmacological action due to over dosage or
prolonged usage.
Ex-coma with barbiturates
24. Scope of Pharmacovigilance
• Improve patient care and safety in relation to the use
of medicines, and all medical and paramedical
interventions
• Improve public health and safety in relation to the use
of medicines
• Contribute to the assessment of benefit, harm,
effectiveness and risk of medicines, encouraging their
safe, rational and more effective (including cost-
effective) use
• Promote understanding, education and clinical training
in pharmacovigilance and its effective communication
with the public